Latest news
CVS Looks 21.7% Overvalued on GF Value™ Despite Solid Dividend Y - GuruFocusGuruFocus · Sat, 08 Aug 2026 14:16:44 GMTCVS Maintains Buy Rating by UBS -- Price Target Raised to $126 - GuruFocusGuruFocus · Fri, 07 Aug 2026 00:30:38 GMTCVS Maintains Outperform Rating -- Price Target Lowered to $125 - GuruFocusGuruFocus · Thu, 06 Aug 2026 18:03:26 GMTCVS Maintained by Barclays -- Price Target Raised to $108 - GuruFocusGuruFocus · Thu, 06 Aug 2026 16:06:27 GMTCVS Looks 34.4% Overvalued on GF Value™ as Dividend Sustainabili - GuruFocusGuruFocus · Thu, 06 Aug 2026 10:45:56 GMTCVS Looks 27.5% Overvalued on GF Value™ as Dividend Sustainabili - GuruFocusGuruFocus · Thu, 06 Aug 2026 10:22:22 GMTCVS Looks 34.4% Overvalued on GF Value™ Amid Solid Dividend Fund - GuruFocusGuruFocus · Thu, 06 Aug 2026 10:20:37 GMTCVS SWOT Analysis: Strong Growth Amidst Valuation Concerns Revea - GuruFocusGuruFocus · Thu, 06 Aug 2026 06:21:02 GMT